Clinical Trials Directory

Trials / Completed

CompletedNCT03028649

The Effect of β-hydroxy-β-methylbutyrate Supplementation on Physical Capacity and Body Composition in Trained Athletes

The Effect of β-hydroxy-β-methylbutyrate (HMB) Supplementation on Physical Capacity and Body Composition in Trained Athletes

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
58 (actual)
Sponsor
Poznan University of Medical Sciences · Academic / Other
Sex
Male
Age
17 Years – 40 Years
Healthy volunteers
Accepted

Summary

The purpose of this study was to verify the effect of 12-week with β-hydroxy-β-methylbutyrate (HMB) and a placebo (PLA) supplementation on body composition, anaerobic and aerobic capacity, as well as concentrations of the selected biochemical blood markers in trained athletes, in a randomised, double-blind, placebo-controlled crossover trial.

Detailed description

The effect of HMB supplementation is of great interest in sport. In view of the inconclusive character of the results of the studies conducted to date and of a relatively low number of studies investigating the effectiveness of HMB supplementation over a longer period on a large population of trained athletes, the aim of this study was to verify the effect of 12-week with HMB and a placebo supplementation on body composition, anaerobic and aerobic capacity, as well as concentrations of the selected biochemical blood markers in trained athletes, in a randomised, double-blind, placebo-controlled crossover trial.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTβ-hydroxy-β-methylbutyrate and a placebo supplementation

Timeline

Start date
2010-01-01
Primary completion
2014-02-01
Completion
2014-02-01
First posted
2017-01-23
Last updated
2017-01-23

Locations

1 site across 1 country: Poland

Source: ClinicalTrials.gov record NCT03028649. Inclusion in this directory is not an endorsement.